Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1634 studies found for:    Recruiting | cancer | United States, Texas
Show Display Options
RSS Create an RSS feed from your search for:
Recruiting | cancer | United States, Texas
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: MRI
2 Recruiting TDM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: TDM1;   Drug: Lapatinib;   Drug: Abraxane
3 Recruiting Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Leuprolide acetate;   Radiation: radiation
4 Recruiting Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer
Condition: Renal Cancers
Intervention: Radiation: Stereotactic Ablative Radiation Therapy
5 Recruiting Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Arimidex with Faslodex;   Drug: Arimidex without Faslodex
6 Recruiting Young-Onset Microsatellite-Stable Colorectal Cancer
Conditions: Colon Cancer;   Rectal Cancer
Interventions: Behavioral: Questionnaires;   Procedure: Blood Draw
7 Recruiting Denosumab for Breast Cancer With Bone Mets
Condition: Breast Cancer
Intervention: Drug: Denosumab
8 Recruiting Biobehavioral Effects of Hypnosis During Breast Cancer Surgery
Conditions: Malignant Neoplasm of Breast;   Breast Cancer
Interventions: Behavioral: Hypnosedation;   Behavioral: Empathic Conversation;   Behavioral: Questionnaires
9 Recruiting Nintedanib For HER2-negative Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast Cancer
Interventions: Drug: BIBF 1120;   Behavioral: Phone Call
10 Recruiting Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Short Breast MRI (SBMRI);   Behavioral: Questionnaire
11 Recruiting MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast Cancer
Interventions: Drug: MK-3475;   Behavioral: Follow Up/Phone Call
12 Recruiting Eliminating Breast Cancer Surgery in Exceptional Responders With Neoadjuvant Systemic Therapy
Condition: Breast Cancer Female
Interventions: Procedure: Breast Biopsy;   Radiation: Radiation Therapy;   Behavioral: Questionnaire
13 Recruiting Genomic Testing for Primary Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Tumor Biopsy;   Other: Breast Cancer Registry
14 Recruiting Phase IIB Neoadjuvant Enzalutamide (ZT) Plus Taxol for Androgen Receptor (AR)-Positive Triple-Negative Breast Cancer (AR+ TNBC)
Condition: Breast Cancer
Interventions: Drug: Enzalutamide;   Drug: Paclitaxel
15 Recruiting Triple-Negative First-Line Study: Neoadjuvant Trial of Nab-Paclitaxel and MPDL3280A, a Pdl-1 Inhibitor in Patients With Triple Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: MPDL3280A;   Drug: Nab-paclitaxel
16 Recruiting The Role of Lifestyle Factors in Breast Cancer-Related Outcomes
Condition: Breast Cancer
Interventions: Behavioral: Aerobic Activity;   Behavioral: Dietician Counseling;   Behavioral: Yoga;   Behavioral: Cognitive Behavior Therapy;   Behavioral: Smoking Cessation Counseling;   Behavioral: Questionnaires;   Other: Saliva Samples;   Behavioral: Dietary Assessment;   Procedure: Blood Samples
17 Recruiting Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Conditions: Ovarian Cancer;   Metastatic Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pembrolizumab
18 Recruiting CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer
Condition: Early-stage Glottic Larynx Cancer
Intervention: Radiation: CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy
19 Recruiting Ramucirumab for Advanced Pre-treated Biliary Cancers
Condition: Biliary Cancer
Intervention: Drug: Ramucirumab
20 Recruiting Women's Triple-Negative First-Line Study: Liposomal Doxorubicin, Bevacizumab and Everolimus (DAE) in Patients With Localized Triple-Negative Breast Cancer (TNBC) With Tumors Predicted Insensitive to Standard Neoadjuvant Chemotherapy
Condition: Breast Cancer
Interventions: Drug: Everolimus;   Drug: Liposomal Doxorubicin;   Drug: Bevacizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.